Evidence map›Paper›PMID 40875497›Full record

ArticleEuropean journal of public health2025

Which women go for screening?

Christine Sevilla-Dedieu, Morgane Le Guern, Céline Coquoz, Nathalie Billaudeau, Alain Paraponaris

Abstract read
In one paragraph

Article in European journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christine Sevilla-DedieuMGEN Foundation for Public Health, Paris, Ile-de-France, France.ORCID 0000-0002-0915-241X
Morgane Le GuernMGEN Foundation for Public Health, Paris, Ile-de-France, France.
Céline CoquozAssistance Publique-Hôpitaux de Paris (APHP), Paris, Ile-de-France, France.
Nathalie BillaudeauMGEN Foundation for Public Health, Paris, Ile-de-France, France.
Alain ParaponarisAix-Marseille Univ, CNRS, AMSE, Marseille, Bouches-du-Rhône, France.ORCID 0000-0001-8281-8305

Funding

Excellence Initiative of Aix-Marseille UniversityExcellence Initiative of Aix-Marseille University-A*MIDEXFrench GovernmentFrench National Research Agency ANR-17-EURE-0020
6 · The paper itself

Abstract

Cancer accounts for approximately one-third of deaths in developed countries. Preventing cancer, notably by detecting new cases early, is thus crucial. In the European Union (EU), screening rates have been recommended for several types of cancer; however, most EU countries are still not meeting them. Determining how we can improve people's adherence to screening is necessary. This study aimed to explore the characteristics of women associated with being up-to-date on mammograms or Pap smears; notably, we wanted to determine the extent to which women's attitudes towards risk play a role in their adherence to screening. The sample comprised 1411 women who responded to a telephone survey. The survey data, including sociodemographic characteristics, health information, attitudes towards the future, and attitudes towards risk, collected via the Domain-Specific Risk-Taking (DOSPERT) scale, were supplemented by medico-administrative data. The factors associated with undergoing either a mammogram or a Pap smear in a timely manner were similar. Two favourable factors were found: the number of children and a high level of education. In contrast, being older or having a higher DOSPERT score for risk-taking appeared to be negatively associated with timely screening. The fact that women's attitudes towards risk seem to have a strong impact on their adherence to medical recommendations is a finding that should be considered (e.g. by health professionals or in prevention campaigns) regarding increasing women's awareness of the importance of regular cancer screening.

Indexed as

Breast NeoplasmsEarly Detection of CancerHealth Knowledge, Attitudes, PracticeMammographyMass ScreeningPapanicolaou TestUterine Cervical NeoplasmsVaginal SmearsAdultAgedFemaleHumansMiddle AgedSurveys and Questionnaires

Identifiers

PMID40875497
PMCPMC12529260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.